The trajectory of companies tied to iconic drugs like Viagra presents a nuanced investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the loss of exclusivity in key markets has introduced substantial volatility. Investors are now grappling with the impact of rival medi